Evidence that contamination by lipopolysaccharide confounds In Vitro studies of adiponectin activity in bone

Endocrinology

Volumn 153, Issue 5, 2012, Pages 2076-2081

  Naot, Dorit ^a   Williams, Garry A ^a   Lin, Jian Ming ^a   Cornish, Jillian ^a   Grey, Andrew ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; INTERFERON; INTERFERON REGULATORY FACTOR 7; LIPOPOLYSACCHARIDE; RANTES; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HEAT; HYPOTHESIS; IN VITRO STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL;

ADIPONECTIN; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; INTERFERON-BETA; LIPOPOLYSACCHARIDES; MALE; MICE; RECEPTORS, ADIPONECTIN;

EID: 84860346202     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-2004     Document Type: Article

References (28)

1. Matsuzawa Y 2010 Adiponectin: a key player in obesity related disorders. Curr Pharm Des 16:1896-1901
2. Ouchi N, Walsh K 2007 Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta 380:24-30 (Pubitemid 46498041)
3. Reid IR 2002 Relationships among body mass, its components, and bone. Bone 31:547-555 (Pubitemid 35449695)
4. Reid IR 2008 Relationships between fat and bone. Osteoporos Int 19:595-606 (Pubitemid 351642171)
5. Reid IR, Cornish J, Baldock PA 2006 Nutrition-related peptides and bone homeostasis. J Bone Miner Res 21:495-500
6. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Bio-phys Res Commun 257:79-83 (Pubitemid 29299050)
7. Jürimäe J, Rembel K, Jürimäe T, Rehand M 2005 Adiponectin is associated with bone mineral density in perimenopausal women. Horm Metab Res 37:297-302 (Pubitemid 40896213)
8. Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freedman BI, Langefeld CD, Carr JJ, Bowden DW 2003 Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33:646-651 (Pubitemid 37222391)
9. Richards JB, Valdes AM, Burling K, Perks UC, Spector TD 2007 Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab 92:1517-1523 (Pubitemid 46556433)
10. Huang CY, Lee CY, Chen MY, Tsai HC, Hsu HC, Tang CH 2010 Adiponectin increases BMP-2 expression in osteoblasts via AdipoR receptor signaling pathway. J Cell Physiol 224:475-483
11. Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M, Sugimoto T 2007 Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol 8:51
12. Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, Liao EY 2006 Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 21:1648-1656 (Pubitemid 44484610)
13. Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD, Wu XP, Liao EY 2005 Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 309:99-109 (Pubitemid 41191227)
14. Williams GA, Wang Y, Callon KE, Watson M, Lin JM, Lam JB, Costa JL, Orpe A, Broom N, Naot D, Reid IR, Cornish J 2009 In vitro and in vivo effects of adiponectin on bone. Endocrinology 150:3603-3610
15. Yamaguchi N, Kukita T, Li YJ, Martinez Argueta JG, Saito T, Hanazawa S, Yamashita Y 2007 Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus ac-tinomycetemcomitans. FEMS Immunol Med Microbiol 49:28-34 (Pubitemid 46160583)
16. Yamaguchi N, Kukita T, Li YJ, Kamio N, Fukumoto S, Nonaka K, Ninomiya Y, Hanazawa S, Yamashita Y 2008 Adiponectin inhibits induction of TNF-α/RANKL-stimulated NFATc1 via the AMPK signaling. FEBS Lett 582:451-456
17. Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H, Shimomura I 2005 Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 331:520-526 (Pubitemid 40602668)
18. Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJ, Reid IR 2001 Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 29:162-168 (Pubitemid 32737190)
19. Cornish J, Callon KE, Naot D, Palmano KP, Banovic T, Bava U, Watson M, Lin JM, Tong PC, Chen Q, Chan VA, Reid HE, Fazzalari N, Baker HM, Baker EN, Haggarty NW, Grey AB, Reid IR 2004 Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145:4366-4374 (Pubitemid 39120586)
20. Reiner A, Yekutieli D, Benjamini Y 2003 Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19:368-375 (Pubitemid 36284936)
21. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(- ΔΔC(T)) method. Methods 25:402-408 (Pubitemid 34164012)
22. Samarajiwa SA, Forster S, Auchettl K, Hertzog PJ 2009 INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res 37:D852-D857
23. Peake PW, Shen Y, Campbell LV, Charlesworth JA 2006 Human adiponectin bindstobacterial lipopolysaccharide. Biochem Biophys Res Commun 341:108-115
24. Turner JJ, Smolinska MJ, Sacre SM, Foxwell BM 2009 Induction of TLR tolerance in human macrophages by adiponectin: does LPS play a role? Scand J Immunol 69:329-336
25. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B 1996 Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun 64:2371-2380 (Pubitemid 26226792)
26. Zou W, Bar-Shavit Z 2002 Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 17:1211-1218 (Pubitemid 34680497)
27. Lee Y, Huang H, Kim HJ, Park CK, Kim HH 2008 The phospha-tidylinositol 3-kinase-mediated production of interferon-β is critical for the lipopolysaccharide inhibition of osteoclastogenesis. Life Sci 83:369-376
28. Itoh K, Udagawa N, Kobayashi K, Suda K, Li X, Takami M, Okahashi N, Nishihara T, Takahashi N 2003 Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J Immunol 170:3688-3695 (Pubitemid 36359239)